Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
see.ip - Details for Therapeutische Mittel zum Targeting des NCCA-ATP-Kanals und Verwendungsverfahren dafür
Details for 2010010752
Up to date per 14.06.2026
Actions
Details for 2010010752
Title / Product Name
Therapeutische Mittel zum Targeting des NCCA-ATP-Kanals und Verwendungsverfahren dafür
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2010010752
EP Publication Number
2382977
E-Number
680715
Language
EN
PCT Number
-
Publication Date
02.11.2011 A
06.08.2014 B1
Registration Date
06.08.2014
AT Publication Date
15.08.2014
Application Date
16.09.2005
Registration Number
-
Priorities
18.09.2004
US
610758 P
11.07.2005
US
698272 P
IPC
A61P 25/00 20060101AFI20140130BHEP
Maximum Duration of Protection
16.09.2025
Owner
University of Maryland, BaltimoreOffice of Research and Development 620 W. Lexington Street, 4th Floor Baltimore, MD 21201US
The United States of America, as represented by the Department of Veterans AffairsDepartment of Veterans Affairs Office of General Counsel - PSG IV (024) 810 Vermont Ave. N.W. Washington, DC 20420US
Representative
No representatives present
Inventor
Simard, Marc J.5223 Springlake Way Baltimore, MD 21212-3421US